术后血糖控制与下肢手术结局的关联
该研究基于Cerner Health Facts数据库,纳入2008年9月至2014年3月因外周动脉疾病接受择期下肢手术的3586例患者,评估术后高血糖(>180 mg/dL)与感染、住院时间、死亡及30天再入院的关系。结果显示22%患者存在术后高血糖,其感染、住院时间延长及院内死亡风险显著增加,但30天再入院率无差异。
要点
- 术后高血糖(>180 mg/dL)与感染风险增加独立相关(OR 1.34)。
- 术后高血糖与住院时间>10天风险增加独立相关(OR 1.69)。
- 术后高血糖与院内死亡风险显著增加独立相关(OR 8.40)。
核心结论
- 术后高血糖与下肢血管手术后的不良事件相关,包括感染、住院利用率增加和死亡,但30天再入院率无差异。
研究设计与样本
- 回顾性队列研究,从Cerner Health Facts数据库筛选2008年9月至2014年3月因外周动脉疾病行择期下肢手术的3586例患者。
主要发现
- 3586例患者中,2812例(78%)术后血糖控制最佳,774例(22%)存在术后高血糖。
- 术后高血糖组平均住院时间6.9天 vs 5.1天(P < .0001),感染率23% vs 14%(P < .0001)。
- 总体30天再入院率为10.9%,两组间无差异(均为10.9%,P = .93);大截肢率两组无差异(P = .21)。
- 多变量logistic回归显示,高血糖组感染并发症的OR为1.34(95%CI 1.06-1.69),住院时间>10天的OR为1.69(95%CI 1.32-2.15),院内死亡的OR为8.40(95%CI 3.95-17.9)。
关键数值与推荐
- 术后高血糖定义为血糖>180 mg/dL。
临床怎么用
- 术后血糖管理可能作为改善下肢血管手术结局的重要质量指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The effect of postoperative hyperglycemia in patients undergoing open and endovascular procedures on the lower extremities has not been fully characterized with regard to associated admission diagnoses, hospital complications, mortality, and 30-day readmission. This study evaluated the relationship of postoperative hyperglycemia on outcomes after lower extremity vascular procedures for peripheral artery disease. METHODS: Patients with peripheral artery disease admitted for elective lower extremity procedures between September 2008 and March 2014 were selected from the Cerner Health Facts (Cerner Corporation, Kansas City, Mo) database using International Classification of Diseases, Ninth Edition, Clinical Modification diagnosis and procedure codes. Using χ2 analysis, we evaluated the relationship of postoperative hyperglycemia (>180 mg/dL) with sociodemographic characteristics, acute and chronic diagnoses, infections, hospital length of stay (LOS), and 30-day readmission. An adjusted multivariable logistic model was used to examine the association of postoperative hyperglycemia with infection and LOS. RESULTS: Of 3586 patients in the study, 2812 (78%) had optimal postoperative glucose control, and 774 (22%) had suboptimal glucose control (hyperglycemia). On average, patients with postoperative hyperglycemia experienced longer hospital stays (6.9 vs 5.1 days; P < .0001), higher Charlson Comorbidity Index scores (3.4 vs 2.5, P < .0001), higher rates of infection (23% vs 14%, P < .0001), more acute complications (ie, fluid and electrolyte disorders, acute renal failure, postoperative respiratory complications), and chronic problems (ie, anemia, chronic heart disease, chronic kidney disease, and diabetes) than patients with optimal glucose control. Overall 30-day readmission was 10.9% and was similar between the groups (10.9% for both; P = .93). Major amputations did not differ between groups (P = .21). After adjusting for other risk factors using multivariable logistic regression, patients with hyperglycemia have 1.3-times the odds to have an infectious complication compared with those with optimal glucose control (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.06-1.69) and 1.7-times the odds to have a hospital LOS >10 days (OR, 1.69; 95% CI, 1.32-2.15). As well, patients with postoperative hyperglycemia have 8.4-times the odds of dying in the hospital (OR, 8.40; 95% CI, 3.95-17.9). CONCLUSIONS: One in five patients undergoing vascular procedures had postoperative hyperglycemia. Postoperative hyperglycemia was associated with adverse events after lower extremity vascular procedures in patients with and without diabetes, including infection, increased hospital utilization, and mortality. No difference was found with respect to hospital readmission. Postprocedure glucose management may represent an important quality marker for improving outcomes after lower extremity vascular procedures.
引用
- Vogel TR, Smith JB, Kruse RL, et al. The association of postoperative glycemic control and lower extremity procedure outcomes. J Vasc Surg. 2017. PMID: 28433336. doi:10.1016/j.jvs.2017.01.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。